Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by the occurrence of vascular thrombosis and/or obstetric complications and is driven by a heterogeneous group of autoantibodies called antiphospholipid antibodies (aPL) [1,2,3]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.